KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 99 filers reported holding KYMERA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $363 | -39.5% | 26,109 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $600 | -22.5% | 26,109 | 0.0% | 0.01% | -25.0% |
| Q1 2023 | $774 | +35.3% | 26,109 | +14.0% | 0.01% | +33.3% |
| Q4 2022 | $572 | -99.9% | 22,910 | -25.7% | 0.01% | -25.0% |
| Q3 2022 | $671,000 | +22.0% | 30,838 | +137.2% | 0.01% | +60.0% |
| Q1 2022 | $550,000 | -33.3% | 13,000 | 0.0% | 0.01% | -28.6% |
| Q4 2021 | $825,000 | +8.0% | 13,000 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $764,000 | +21.1% | 13,000 | 0.0% | 0.01% | +16.7% |
| Q2 2021 | $631,000 | +25.0% | 13,000 | 0.0% | 0.01% | +20.0% |
| Q1 2021 | $505,000 | -37.3% | 13,000 | 0.0% | 0.01% | -37.5% |
| Q4 2020 | $806,000 | +91.9% | 13,000 | 0.0% | 0.01% | +60.0% |
| Q3 2020 | $420,000 | – | 13,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,858,262 | $81,429,842 | 12.61% |
| Aquilo Capital Management, LLC | 782,219 | $10,872,844 | 9.85% |
| BVF INC/IL | 4,739,004 | $65,872,156 | 1.78% |
| Redmile Group, LLC | 1,868,507 | $25,972,247 | 1.24% |
| Artal Group S.A. | 1,805,346 | $25,094 | 1.08% |
| Deer Management Co. LLC | 615,895 | $8,560,941 | 1.04% |
| Avoro Capital Advisors LLC | 3,855,000 | $53,584,500 | 0.84% |
| Rock Springs Capital Management LP | 1,504,351 | $20,910,479 | 0.56% |
| AtonRa Partners | 19,172 | $266,491 | 0.56% |
| Baker Brothers Advisors | 4,750,400 | $66,030,560 | 0.38% |